NCT06208384View on ClinicalTrials.gov

Topical Statin Eye Drop in the Management of the Dry Eye

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 4, 2024

Primary Completion Date

January 4, 2025

Study Completion Date

February 4, 2025

Conditions
Dry Eye Disease
Interventions
DRUG

Statin eye drop

Use of topical atorvastatin eye 8 times a day; in addition to eyelid hygiene and artificial tear drops (8 weeks)

DRUG

Placebo

Use of topical eye drops as a placebo same as intervention group but without active ingredient of atorvastatin 8 times a day; in addition to eyelid hygiene and artificial tear drops (8 weeks)

Trial Locations (1)

Unknown

Ophthalmic Research Center, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER